secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2024-07-24T23:59:59+00:00
Accession:  0001493152-24-028854
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics shareholders approve increase in authorized shares, re-elect directors
--------------------------------------------------------------------------------

- Stockholders re-elected Dr. Lishan Aklog, Debra White, and Dennis Matheis as Class C directors.
- Approved amendment to increase authorized common stock from 200M to 300M shares.
- Approved issuance of shares under Series B and B-1 Convertible Preferred Stock for Nasdaq Listing Rule 5635.
- Ratified appointment of Marcum LLP as independent auditor for FY 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315224028854/0001493152-24-028854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315224028854/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-028854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer